About Azra
Azra is a company based in Franklin (United States) founded in 2022 by Chris Cashwell. Azra has raised $7.95 million across 2 funding rounds. Azra has completed 1 acquisition, including Thynk Health. Azra offers products and services including Cancer Patient Identification, Screening and Incidental Findings, Cancer Registry Automation, Tumor Board, and Patient Care Management. Azra operates in a competitive market with competitors including Valar Labs, NEOGAP, Oncora, Cambridge Cancer Genomics and Cyted, among others.
- Headquarter Franklin, United States
- Founders Chris Cashwell
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.95 M (USD)
in 2 rounds
-
Latest Funding Round
$1.9 M (USD), Series A
Jun 06, 2025
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Azra
Azra offers a comprehensive portfolio of products and services, including Cancer Patient Identification, Screening and Incidental Findings, Cancer Registry Automation, Tumor Board, and Patient Care Management.
Identifies cancer from reports in real-time for faster treatment.
Detects high-risk patients from radiology reports promptly.
Automates case finding and data abstraction for registries.
Simplifies reviews and documentation for cancer treatment planning.
Manages journeys from diagnosis through survivorship efficiently.
Provides actionable reports for oncology decision-making.
Offers insights to optimize oncology service lines.
Assesses and optimizes healthcare workflows for better outcomes.
People of Azra
Unlock access to complete
Leadership Team
2 people
Product Management Team
2 people
CTO Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Azra
Azra has successfully raised a total of $7.95M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.9 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Azra
Azra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Thynk Health.
Investment portfolio details for Azra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A lung cancer screening platform is provided using AI-based software.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Azra
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Azra
Detailed financials for Azra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Azra Comparisons
Peer comparison for Azra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Azra
Azra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Valar Labs, NEOGAP, Oncora, Cambridge Cancer Genomics and Cyted, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI software for oncology treatment planning is provided to providers.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for cancer treatment are developed using advanced technologies.
|
|
| Locked | Locked | Locked |
AI-based clinical data analysis and decision support tool for oncologists
|
|
| Locked | Locked | Locked |
Developer of AI-based precision medicine tools for oncologists
|
|
| Locked | Locked | Locked |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
Detailed competitors of Azra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Azra
Complete news archive for Azra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azra
Azra was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Azra is headquartered in Franklin, United States.
Chris Cashwell is the current CEO of Azra. They have also founded this company.
Azra is a funded company, having raised a total of $7.95M across 2 funding rounds to date.
Azra was founded in 2022 and is based in Franklin, United States. Operations focus on the health technology sector, where AI and machine learning are applied to oncology. Cancer diagnoses and incidental findings are identified, classified, and abstracted from pathology and radiology reports. Oncology operations are managed across clinical, financial, and operational aspects, including patient identification, report generation, data population, and compliance handling.
Azra's top competitors include Valar Labs, NEOGAP and Cambridge Cancer Genomics.
Azra offers Cancer Patient Identification, Screening and Incidental Findings, Cancer Registry Automation, Tumor Board, and 4 more products and services.
Azra has made 1 acquisition, including Thynk Health.